S

Synthaverse SA
WSE:SVE

Watchlist Manager
Synthaverse SA
WSE:SVE
Watchlist
Price: 4.14 PLN -2.47% Market Closed
Market Cap: 293m PLN
Have any thoughts about
Synthaverse SA?
Write Note

Synthaverse SA
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Synthaverse SA
Accrued Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
S
Synthaverse SA
WSE:SVE
Accrued Liabilities
zł7m
CAGR 3-Years
27%
CAGR 5-Years
20%
CAGR 10-Years
26%
M
Mabion SA
WSE:MAB
Accrued Liabilities
zł3.1m
CAGR 3-Years
-12%
CAGR 5-Years
26%
CAGR 10-Years
41%
R
Read Gene SA
WSE:RDG
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
G
Genomed SA
WSE:GEN
Accrued Liabilities
zł143.5k
CAGR 3-Years
-10%
CAGR 5-Years
24%
CAGR 10-Years
N/A
B
Bioton SA
WSE:BIO
Accrued Liabilities
zł37.5m
CAGR 3-Years
-5%
CAGR 5-Years
2%
CAGR 10-Years
8%
U
Urteste SA
WSE:URT
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Synthaverse SA
Glance View

Market Cap
292m PLN
Industry
Biotechnology

Biomed Lublin Wytwornia Surowic i Szczepionek SA engages in the manufacture of pharmaceutical products. The company is headquartered in Lublin, Woj. Lubelskie and currently employs 234 full-time employees. The company went IPO on 2011-07-29. The firm focuses on the production of drugs in the field of immunotherapy. Synthaverse SA offers its services in the field such as: oncological immunotherapy, Immunotherapy in Serological Conflict, Passive immunotherapy in hepatitis B, Active anti-tuberculosis immunotherapy, Gynecology and Proctology, Probiotics, Laboratory reagents. The firm offers injection drugs, lyophilisates of active substances in sterile sealed vials, active substances and drugs based on surface and submerged biological culture, suppository forms of drugs. The firm supplies its products to 50 countries around the world.

SVE Intrinsic Value
6.96 PLN
Undervaluation 40%
Intrinsic Value
Price
S

See Also

What is Synthaverse SA's Accrued Liabilities?
Accrued Liabilities
7m PLN

Based on the financial report for Jun 30, 2024, Synthaverse SA's Accrued Liabilities amounts to 7m PLN.

What is Synthaverse SA's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
26%

Over the last year, the Accrued Liabilities growth was 70%. The average annual Accrued Liabilities growth rates for Synthaverse SA have been 27% over the past three years , 20% over the past five years , and 26% over the past ten years .

Back to Top